powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1538508296
Mary Wells
MD
Hematology-Oncology
Omaha,
NE
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$91
Payment records
4
By payment type
Food and Beverage
$91
PRESCRIBING · PART D · 2024
Total Rx claims
1,599
Beneficiaries
—
Total drug cost
$1.4M
Distinct drugs
32
Brand share
16.7%
Top prescribed drugs
Letrozole
435 claims
Ondansetron Hcl
107 claims
Tamoxifen Citrate
86 claims
Dexamethasone
79 claims
Prochlorperazine Maleate
73 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,065
Unique beneficiaries
—
Total services
70,817
Distinct HCPCS
49
Medicare payment
$786K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 28 Hematology-Oncology providers in NE — above median (cohort median 149,484).